Who is sponsoring NCT05197647?

NCT05197647 is sponsored by Hospital Moinhos de Vento.

What drugs are being tested in NCT05197647?

Interventions in NCT05197647: Patients with symptomatic COVID-19 disease not requiring hospitalization..

What condition does NCT05197647 study?

NCT05197647 studies COVID-19, Quality of Life, Disability Physical, Disabilities Mental.

Is NCT05197647 still recruiting?

NCT05197647 is currently status unknown. Last updated 7 November 2023.

Last reviewed 2023-11-07 · How we verify

NCT05197647

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil

Status unknown Last updated 7 November 2023

What this trial tests

trial testing Patients with symptomatic COVID-19 disease not requiring hospitalization. in COVID-19 in 1,085 participants. Status unknown.

Timeline

25 January 2022

Primary endpoint
20 December 2023

20 July 2024

Quick facts

Lead sponsor	Hospital Moinhos de Vento
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,085
Start date	25 January 2022
Primary completion	20 December 2023
Estimated completion	20 July 2024
Sites	14 locations across Brazil

Drugs / interventions tested

Patients with symptomatic COVID-19 disease not requiring hospitalization.

Conditions studied

COVID-19 — all drugs for COVID-19 →
Quality of Life — all drugs for Quality of Life →
Disability Physical — all drugs for Disability Physical →
Disabilities Mental — all drugs for Disabilities Mental →

Sponsor

Hospital Moinhos de Vento

Who can join

18 and older, any sex, with COVID-19 or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult patients with mild COVID-19. Adult patients with symptomatic COVID-19 not requiring hospitalization will be followed through structured and centralized telephone interviews performed at 1, 3, 6, 9 and 12 months after enrollment.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study.
Rover MM, Scolari FL, Trott G, da Silva MMD, et al · · 2024 · cited 5× · PMID 39582794 · DOI 10.1016/j.jvacx.2024.100579
Health-Related Quality of Life and Long-Term Outcomes after Mildly Symptomatic COVID-19: The Post-COVID Brazil Study 2 Protocol.
Rover MM, Trott G, Scolari FL, Silva MMDD, et al · · 2023 · cited 4× · PMID 37851732 · DOI 10.36660/abc.20220835
Impact of long COVID phenotypes on quality of life following symptomatic omicron infection in Brazil: a machine learning analysis.
Scolari FL, Spinardi J, Silva MMDD, Trott G, et al · · 2025 · PMID 41204118 · DOI 10.1186/s12879-025-11956-6

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Hospital Moinhos de Vento trials

Trials by the same sponsor.

NCT07186517 — Genetic Variants in Stroke · not yet recruiting
NCT05996861 — Protocol For Sleep for Critically Ill Patients · unknown
NCT05306600 — Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System · recruiting
NCT05572736 — Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure · NA · completed
NCT06903260 — Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05197647 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Moinhos de Vento
Last refreshed: 7 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05197647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing